Holen Sie sich die Stockscreener-App
89.35
1.61%
1.42
Handel nachbörslich:
89.60
0.25
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
DexCom Inc Share PriceDXCM, RNS News, Articles, Quotes, & Charts (NASDAQ:DXCM) - Proactive financial news
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
DexCom (DXCM) Expands Board to 13 Directors with Appointment of Glenn S. Boehnlein - GuruFocus
Dexcom stock heads into the open after a 0.8% Nasdaq pullback - ad-hoc-news.de
Dexcom Appoints Glenn Boehnlein to Board of Directors - BioSpace
DexCom Expands Board with Glenn Boehnlein Appointment and Details Compensation Plan - Kalkine Media
DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026 - marketscreener.com
Dexcom (NASDAQ: DXCM) director gets 5,841-unit stock grant vesting over 3 years - Stock Titan
Dexcom (DXCM) director discloses 42-share trust stake - Stock Titan
DexCom, Inc. (DXCM) latest stock news and headlines - Yahoo Finance UK
DexCom appoints Glenn S. Boehnlein to Board and committees - TradingView
Dexcom (NASDAQ: DXCM) officer lines up six‑figure stock sale - Stock Titan
How Dexcom Inc. (DXCM) Affects Rotational Strategy Timing - Stock Traders Daily
Dexcom Inc. stock steadies near mid-range as conference outlines growth plan - ad-hoc-news.de
DexCom expects CONNECT study on type 2 diabetes to be published soon in a major journal. - Pluang
Dexcom at Wells Fargo conference: coverage push drives growth plan By Investing.com - Investing.com India
Transcript : DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM - marketscreener.com
DexCom Stock: Is DXCM Underperforming the Healthcare Sector? - webull.com
Dexcom stock heads into the open after a 3.8 percent drop - ad-hoc-news.de
Kakao Healthcare Lends Glucose Monitors to Diabetic Exam Takers - Seoul Economic Daily
DexCom Inc (DXCM) Shares Fall 3.8% -- What GF Score of 95 Tells Investors - GuruFocus
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Law firm probes DexCom officers for possible br... - Pluang
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
DexCom, Inc. (DXCM) Stock Analysis: A Strong Buy With 7% Upside Potential - DirectorsTalk Interviews
Dexcom Inc. stock holds near consensus target on solid Q2 2026 growth - ad-hoc-news.de
Dexcom stock holds near USD 89.71 after strong Q2 - AD HOC NEWS
DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair - Yahoo Finance
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks - finance.yahoo.com
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services - Barron's
ETFs Investing in DexCom, Inc. Stocks - TradingView
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term - Eastern Progress
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
3 Reasons DXCM Has Explosive Upside Potential - finance.yahoo.com
Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today - qz.com
Dexcom Announces Upcoming Conference Presentation - Business Wire
G7 Momentum and Global Reach Might Change The Case For Investing In DexCom (DXCM) - simplywall.st
DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings And A Promising 3.63% Upside - DirectorsTalk Interviews
Dexcom (DXCM) HR chief cashes out 2,565 company shares - stocktitan.net
Dexcom Defeats Investor Suit Over Glucose Monitor Market Share - Bloomberg Law News
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Sahm
DexCom (NASDAQ: DXCM) officer may sell 2,565 shares on Aug. 27, 2026 - Stock Titan
We Ran A Stock Scan For Earnings Growth And DexCom (NASDAQ:DXCM) Passed With Ease - Moomoo
Dexcom (NASDAQ: DXCM) officer keeps 101,502 shares after tax withholding - Stock Titan
Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now? - Eastern Progress
Dexcom (NASDAQ: DXCM) CEO retains 418,908 shares after tax withholding - Stock Titan
Dexcom (NASDAQ: DXCM) chair sells 26,756 shares around $90 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages DexCom, Inc. (DXCM) - The National Law Review
DexCom (NASDAQ:DXCM) Reaches New 52-Week HighStill a Buy? - MarketBeat
DexCom stock hits 52-week high at 91.99 USD - Investing.com
DexCom Study Demonstrates CGM Benefits in Type 2 Diabetes - Medical Product Outsourcing
DXCM Shareholders Have Opportunity to Lead DexCom, Inc. Class Act - The National Law Review
DexCom posts $1.31B quarter as Silvant Capital opens a $5.4M stake - Dealroom
Silvant Capital Management LLC Takes $5.36 Million Position in DexCom, Inc. $DXCM - MarketBeat
Trillium Asset Management LLC Invests $3.23 Million in DexCom, Inc. $DXCM - MarketBeat
Danske Bank A S Purchases New Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom (NASDAQ:DXCM) Combines Strong Growth With a Bullish Technical Setup - ChartMill
Dexcom stock holds close to analyst target as growth story stays intact - Ad-hoc-news.de
E Fund Management Co. Ltd. Acquires New Holdings in DexCom, Inc. $DXCM - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $5.01 Million in DexCom, Inc. $DXCM - MarketBeat
Deutsche Bank AG Takes Position in DexCom, Inc. $DXCM - MarketBeat
Aurora Investment Counsel Invests $2.34 Million in DexCom, Inc. $DXCM - MarketBeat
Dexcom (NASDAQ: DXCM) Kevin R. Sayer plans multimillion-dollar stock sale - Stock Titan
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DexCom, Inc. $DXCM - MarketBeat
0.49%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):